Frederick L. Locke

3 ta ish

Moffitt Cancer Center

1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

   Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37

   Maqola20174 iqtibos

   ABIABI:AkademIndex/2026.other.296830

2. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

   Frederick L. Locke, David B. Miklos, Caron A. Jacobson +28

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.319265

3. CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations

   Fabiana Perna, Samir Parekh, Caroline Diorio +5

   Sharh maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.480565